Literature DB >> 24190152

Rifampicin-induced acute kidney injury during the initial treatment for pulmonary tuberculosis: a case report and literature review.

Sahoko Chiba1, Kimitake Tsuchiya, Hiroyuki Sakashita, Eisaku Ito, Naohiko Inase.   

Abstract

A 47-year-old man diagnosed with pulmonary tuberculosis was referred to our hospital. Rifampicin, isoniazid, pyrazinamide and ethambutol were administered, and the patient's symptoms promptly improved. On the 19th hospital day, he developed acute kidney injury with a fever and chills. Renal biopsy specimens indicated tubulointerstitial nephritis. Suspecting rifampicin-induced acute kidney injury, we discontinued the rifampicin and administered levofloxacin in its place. The patient's serum creatinine level subsequently gradually improved. We herein report this case and review eight cases reported in Japan. We found that the rifampicin toxicity appeared at both the initial administration and readministration. All eight patients presented with proteinuria.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24190152     DOI: 10.2169/internalmedicine.52.0634

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  11 in total

1.  The drugs that mostly frequently induce acute kidney injury: a case - noncase study of a pharmacovigilance database.

Authors:  Marion Pierson-Marchandise; Valérie Gras; Julien Moragny; Joelle Micallef; Louise Gaboriau; Sylvie Picard; Gabriel Choukroun; Kamel Masmoudi; Sophie Liabeuf
Journal:  Br J Clin Pharmacol       Date:  2017-03-14       Impact factor: 4.335

2.  Rifampicin-Induced Concomitant Renal Injury and Hepatitis.

Authors:  Bharti Chogtu; Vyshak Uddur Surendra; Rahul Magazine; Preetam Rajgopal Acharya; Devesh Bhaskar Yerrapragada
Journal:  J Clin Diagn Res       Date:  2016-09-01

3.  Effect of DOTS Treatment on Vitamin D Levels in Pulmonary Tuberculosis.

Authors:  Akshatha Lalesh Naik; Madan Gopal Rajan; Poornima A Manjrekar; Mamatha T Shenoy; Souparnika Shreelata; Rukmini Mysore Srikantiah; Anupama Hegde
Journal:  J Clin Diagn Res       Date:  2017-04-01

4.  Acute Tubular Necrosis and Thrombocytopenia Associated With Rifampin Use: Case Report and Review.

Authors:  Emma L Smith; Laura Bywater; Rebecca Pellicano; Grant A Jenkin; Tony M Korman
Journal:  Open Forum Infect Dis       Date:  2022-05-17       Impact factor: 4.423

5.  Early Detection of Acute Drug-Induced Liver Injury in Mice by Noninvasive Near-Infrared Fluorescence Imaging.

Authors:  Kristine O Vasquez; Jeffrey D Peterson
Journal:  J Pharmacol Exp Ther       Date:  2017-01-23       Impact factor: 4.030

6.  The combined fixed-dose antituberculous drugs alter some reproductive functions with oxidative stress involvement in wistar rats.

Authors:  O Awodele; A A Momoh; N A Awolola; O E Kale; W O Okunowo
Journal:  Toxicol Rep       Date:  2016-07-19

7.  Modulatory and regenerative potential of transplanted bone marrow-derived mesenchymal stem cells on rifampicin-induced kidney toxicity.

Authors:  Lawal Danjuma; Pooi Ling Mok; Akon Higuchi; Rukman Awang Hamat; Seoh Wei Teh; Avin Ee-Hwan Koh; Murugan A Munusamy; Palanisamy Arulselvan; Mariappan Rajan; Arivudai Nambi; K B Swamy; Kiruthiga Vijayaraman; Kadarkarai Murugan; Kalimuthusamy Natarajaseenivasan; Suresh Kumar Subbiah
Journal:  Regen Ther       Date:  2018-09-25       Impact factor: 3.419

8.  Minimal change disease related to rifampicin presenting with acute renal failure during treatment for latent tuberculosis infection: A case report.

Authors:  Jee-Seon Kim; Kyong-Ju Kim; Eun-Young Choi
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

9.  Rifampicin-induced nephrotoxicity in a tuberculosis patient.

Authors:  Alexandria Beebe; Barbara Seaworth; Naveen Patil
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2015-10-24

10.  Toxicity associated with tuberculosis chemotherapy in the REMoxTB study.

Authors:  Conor D Tweed; Angela M Crook; Evans I Amukoye; Rodney Dawson; Andreas H Diacon; Madeline Hanekom; Timothy D McHugh; Carl M Mendel; Sarah K Meredith; Michael E Murphy; Saraswathi E Murthy; Andrew J Nunn; Patrick P J Phillips; Kasha P Singh; Melvin Spigelman; Genevieve H Wills; Stephen H Gillespie
Journal:  BMC Infect Dis       Date:  2018-07-11       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.